PRESS RELEASE published on 10/29/2024 at 11:46, 1 year 10 months ago Pentixapharm Holding AG: US National Cancer Institute Starts Advanced Clinical Trial with PentixaFor US National Cancer Institute initiates clinical trial with PentixaFor, a new radioactive tracer, to aid in identifying adrenal tumors through PET scans, potentially benefiting patients with aldosteronism and Cushing's syndrome Clinical Trial PentixaFor Adrenal Tumors PET Scans NIH
BRIEF published on 10/28/2024 at 12:31, 1 year 10 months ago Nuclear Medicine Expert Ken Herrmann Joins Pentixapharm's Board Supervisory Board Nuclear Medicine Radiopharmaceuticals Oncology Pipeline Ken Herrmann
BRIEF published on 10/28/2024 at 12:31, 1 year 10 months ago Ken Herrmann, expert en médecine nucléaire, rejoint le conseil d'administration de Pentixapharm Conseil De Surveillance Produits Radiopharmaceutiques Médecine Nucléaire Ken Herrmann Pipeline En Oncologie
PRESS RELEASE published on 10/28/2024 at 12:26, 1 year 10 months ago Nuclear Medicine Specialist Ken Herrmann Joins Supervisory Board of Pentixapharm Holding AG Nuclear Medicine Specialist Ken Herrmann joins Pentixapharm Holding AG's Supervisory Board, bringing expertise in radiopharmaceuticals and theranostics. His appointment aims to advance oncology pipeline Oncology Nuclear Medicine Radiopharmaceuticals Pentixapharm Ken Herrmann
BRIEF published on 10/25/2024 at 16:05, 1 year 10 months ago Pentixapharm Holding AG Announces Leadership Changes Leadership Changes Supervisory Board Pentixapharm Dr. Hakim Bouterfa Dr. Dirk Pleimes
BRIEF published on 10/25/2024 at 16:05, 1 year 10 months ago Pentixapharm Holding AG annonce des changements au sein de sa direction Conseil De Surveillance Changements De Direction Pentixapharm Docteur Hakim Bouterfa Dr Dirk Pleimes
PRESS RELEASE published on 10/25/2024 at 16:00, 1 year 10 months ago Pentixapharm Holding AG: Upcoming Changes in the Management and Supervisory Boards of the Pentixapharm Group Pentixapharm Holding AG announces upcoming changes in management and supervisory boards, including CEO transition and new board appointments CEO Transition Supervisory Board Management Changes Pentixapharm Holding AG Nuclear Medicine Specialist
BRIEF published on 10/19/2024 at 12:33, 1 year 11 months ago Pentixapharm's CXCR4 Compound Showcased at EANM Conference Radiopharmaceuticals Pentixapharm CXCR4 Targeting EANM Conference Theranostic Development
BRIEF published on 10/19/2024 at 12:33, 1 year 11 months ago Le composé CXCR4 de Pentixapharm présenté à la conférence EANM Produits Radiopharmaceutiques Pentixapharm Ciblage CXCR4 Conférence EANM Développement Théranostique
PRESS RELEASE published on 10/19/2024 at 12:28, 1 year 11 months ago Pentixapharm’s CXCR4 Core Compound Subject of 17 Abstract Presentations at the Hamburg European Association of Nuclear Medicine (EANM) Pentixapharm presents CXCR4 targeting compounds in 17 abstracts at EANM Congress, showcasing theranostic developments and research initiatives in various medical areas Radiopharmaceuticals Pentixapharm Theranostic Development CXCR4 EANM Congress
Published on 09/24/2026 at 22:01, 1 hour 9 minutes ago Fermi Selects CBRE to Operate and Maintain Its First Data Center
Published on 09/24/2026 at 14:55, 8 hours 15 minutes ago Nextech3D.ai Surpasses $1 Million in New Customer Contract Value, Expands AI Software Portfolio with KATE and Grows Multi-Year Enterprise Agreements
Published on 09/24/2026 at 14:30, 8 hours 40 minutes ago Solitario Resources CEO to Present at the 38th Annual Mining Forum Americas 2026 Conference
Published on 09/24/2026 at 14:00, 9 hours 10 minutes ago Horizon Aircraft to Report First Quarter 2027 Results and Provide a Business Update on October 9, 2026
Published on 09/24/2026 at 20:29, 2 hours 41 minutes ago EQS-Adhoc: HelloFresh SE expects revenue for Q3 2026 below market expectations and adjusts outlook for the financial year 2026
Published on 09/24/2026 at 19:00, 4 hours 10 minutes ago HIAG provides a first-hand insight into its strategy and the added value it generates at its Capital Market Day
Published on 09/24/2026 at 18:40, 4 hours 29 minutes ago EQS-Adhoc: Brockhaus Technologies AG launches public share buyback offer of approx. €90 million for up to 3,592,000 shares
Published on 09/24/2026 at 18:15, 4 hours 55 minutes ago Epanko Value Engineering Identifies 20% Production Increase
Published on 09/24/2026 at 18:05, 5 hours 4 minutes ago DCK Tools Showcases Expanded Outdoor Power Equipment Lineup at Salonvert 2026
Published on 09/24/2026 at 18:31, 4 hours 38 minutes ago LNA SANTE : Mise à disposition du rapport financier semestriel 2026
Published on 09/24/2026 at 18:00, 5 hours 10 minutes ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2026
Published on 09/24/2026 at 18:00, 5 hours 10 minutes ago GUILLEMOT CORPORATION : Mise à disposition du rapport financier semestriel au 30 juin 2026